Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysis.

Published in: Journal of endocrinological investigation (2021)

In the absence of randomized controlled trials, observational research available so far provides inconclusive results and insufficient evidence to recommend use of DPP4i against COVID-19.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
type diabetes
cross sectional
skeletal muscle